Xingzhi Xu
Professor, Executive Dean, Shenzhen University, Shenzhen, Guangdong · China
Editorial leadership for Journal of Chromosomes
Research interests
- Cell Culture
- Cancer Biology
- Molecular Biology
- Cell Biology
- Oncology
- Dna Damage
- Cancer Therapy
Biography
Honors:
1. Editorial board, DNA Repair (IF: 3.1): 2009-present
2. Guest editor, DNA Repair special issue (volume 11 issue 2, 2012): DNA damage research in China: 2012
3. Editorial board, Scientific Reports (IF: 5.5): 2014-present
4. NSFC review panel (Biochemistry & Molecular Biology): 2009-2016
5. NSFC review panel (Oncology): 2012, 2014, 2016, 2017
6. NSFC review panel (International Collaborative Program in Life Sciences): 2015
7. Executive director, Beijing Society for Cell Biology: 2009-2017
8. Associate director, Chinese Society for Cell Biology Signal Transduction Branch: 2016-2019
9. 2015 Distinguish Doctorate Alumni Award, University of South Carolina School of Medicine.
Selected publications
- UFMylation: A Unique & Fashionable Modification for Life 2016 cited 83×
- PARP1 and CHK1 coordinate PLK1 enzymatic activity during the DNA damage response to promote homologous recombination-mediated repair 2021 cited 55×
- Checkpoint kinase 1–induced phosphorylation of O-linked β-N-acetylglucosamine transferase regulates the intermediate filament network during cytokinesis 2017 cited 47×
- TRIM21 suppresses CHK1 activation by preferentially targeting CLASPIN for K63-linked ubiquitination 2022 cited 47×
- Dynamic switching of crotonylation to ubiquitination of H2A at lysine 119 attenuates transcription–replication conflicts caused by replication stress 2022 cited 45×
- A 1,2,3-Triazole Derivative of Quinazoline Exhibits Antitumor Activity by Tethering RNF168 to SQSTM1/P62 2022 cited 36×
Ranked by citation impact (Crossref) where available, newest otherwise · verified via ORCID.
Considering JC for your work?
This journal is guided by Xingzhi Xu (Professor, Executive Dean, Shenzhen University, Shenzhen, Guangdong) and a peer-review board of practising researchers. Open access, author-retained copyright (CC BY), and a clear editorial process.